NCT03797937View on ClinicalTrials.gov

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

November 1, 2021

Study Completion Date

May 1, 2022

Conditions
Multiple Sclerosis
Interventions
OTHER

Magnetic resonance imaging (MRI)

MRI scanner

Trial Locations (2)

1090

Universitair Ziekenhuis Brussel, Jette

1820

Nationaal Multiple Sclerose Centrum Melsbroek, Melsbroek

All Listed Sponsors
lead

National MS Center Melsbroek

OTHER

NCT03797937 - Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II | Biotech Hunter | Biotech Hunter